» Articles » PMID: 34983623

Histone Lysine-specific Demethylase 1 Induced Renal Fibrosis Via Decreasing Sirtuin 3 Expression and Activating TGF-β1/Smad3 Pathway in Diabetic Nephropathy

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2022 Jan 5
PMID 34983623
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Diabetic nephropathy (DN) is the leading cause of end-stage renal disease. Histone lysine-specific demethylase 1 (LSD1) is a flavin-containing amino oxidase that can repress or activate transcription. The aim of this study is to explore the mechanism of LSD1 aggravating DN-induced renal fibrosis.

Methods: The STZ-induced DN rat model was established for in vivo study. The rats were divided into four groups: Sham, STZ, STZ + Ad-shNC and Ad-shLSD1. The Hematoxylin-eosin (HE) staining was used to evaluate the renal injury. The Immunofluorescence assay was used to determine the LSD1, Fibronectin and α-SMA expression. The related protein expression was detected by western blot.

Results: Knockdown of LSD1 alleviated STZ-induced renal injury. Moreover, knockdown of LSD1 decreased the expression of serum biochemical markers, containing urine output (24 h), urinary protein (24 h), serum creatinine, BUN and UACR. Furthermore, we proved that knockdown of LSD1 alleviated renal fibrosis in STZ-induced DN rats. In vitro, knockdown of LSD1 suppressed NRK-49F cells activation and overexpression of LSD1 induced renal fibrosis. In addition, knockdown of LSD1 could deactivate TGF-β1/Smad3 pathway and promote sirtuin 3 (SIRT3) expression in vivo and in vitro. The rescue experiments confirmed that LSD1 induced renal fibrosis via decreasing SIRT3 expression and activating TGF-β1/Smad3 pathway.

Conclusion: LSD1 deficiency leads to alleviate STZ-induced renal injury and overexpression of LSD1 induces renal fibrosis via decreasing SIRT3 expression and activating TGF-β1/Smad3 pathway, which provides a reasonable strategy for developing novel drugs targeting LDS1 to block renal fibrosis.

Citing Articles

Role of Histone Modifications in Kidney Fibrosis.

Pan S, Yuan T, Xia Y, Yu W, Zhou X, Cheng F Medicina (Kaunas). 2024; 60(6).

PMID: 38929505 PMC: 11205584. DOI: 10.3390/medicina60060888.


MYCT1 attenuates renal fibrosis and tubular injury in diabetic kidney disease.

Li X, Fan Q, Ma T, Liu C, Shi H, Sun Y iScience. 2023; 26(9):107609.

PMID: 37664593 PMC: 10470386. DOI: 10.1016/j.isci.2023.107609.


Immunometabolism changes in fibrosis: from mechanisms to therapeutic strategies.

Feng L, Chen X, Huang Y, Zhang X, Zheng S, Xie N Front Pharmacol. 2023; 14:1243675.

PMID: 37576819 PMC: 10412938. DOI: 10.3389/fphar.2023.1243675.


Sex-specific epigenetic programming in renal fibrosis and inflammation.

Kumar P, Brooks H Am J Physiol Renal Physiol. 2023; 325(5):F578-F594.

PMID: 37560775 PMC: 11550885. DOI: 10.1152/ajprenal.00091.2023.


Biochanin A Ameliorates Nephropathy in High-Fat Diet/Streptozotocin-Induced Diabetic Rats: Effects on NF-kB/NLRP3 Axis, Pyroptosis, and Fibrosis.

Ram C, Gairola S, Verma S, Mugale M, Bonam S, Murty U Antioxidants (Basel). 2023; 12(5).

PMID: 37237918 PMC: 10215298. DOI: 10.3390/antiox12051052.


References
1.
Bindu S, Pillai V, Kanwal A, Samant S, Mutlu G, Verdin E . SIRT3 blocks myofibroblast differentiation and pulmonary fibrosis by preventing mitochondrial DNA damage. Am J Physiol Lung Cell Mol Physiol. 2016; 312(1):L68-L78. PMC: 5283928. DOI: 10.1152/ajplung.00188.2016. View

2.
Yang Y, Wang X, Zhang Y, Yuan W . The histone demethylase LSD1 promotes renal inflammation by mediating TLR4 signaling in hepatitis B virus-associated glomerulonephritis. Cell Death Dis. 2019; 10(4):278. PMC: 6427019. DOI: 10.1038/s41419-019-1514-4. View

3.
Yadav H, Quijano C, Kamaraju A, Gavrilova O, Malek R, Chen W . Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling. Cell Metab. 2011; 14(1):67-79. PMC: 3169298. DOI: 10.1016/j.cmet.2011.04.013. View

4.
AL B Vasanth Rao V, Tan S, Candasamy M, Bhattamisra S . Diabetic nephropathy: An update on pathogenesis and drug development. Diabetes Metab Syndr. 2019; 13(1):754-762. DOI: 10.1016/j.dsx.2018.11.054. View

5.
Chen T, Li J, Liu J, Li N, Wang S, Liu H . Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-β/Smad3 pathway. Am J Physiol Heart Circ Physiol. 2014; 308(5):H424-34. DOI: 10.1152/ajpheart.00454.2014. View